DENTSPLY SIRONA Inc. to Post Q2 2023 Earnings of $0.45 Per Share, Jefferies Financial Group Forecasts (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) – Analysts at Jefferies Financial Group decreased their Q2 2023 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a research report issued on Monday, November 21st. Jefferies Financial Group analyst B. Couillard now anticipates that the medical instruments supplier will post earnings per share of $0.45 for the quarter, down from their prior estimate of $0.49. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.96 per share. Jefferies Financial Group also issued estimates for DENTSPLY SIRONA’s FY2023 earnings at $1.80 EPS.

A number of other research analysts have also recently issued reports on the company. StockNews.com started coverage on DENTSPLY SIRONA in a research note on Wednesday, October 12th. They set a “hold” rating for the company. TheStreet cut DENTSPLY SIRONA from a “c” rating to a “d” rating in a research note on Monday, November 14th. William Blair reissued an “underperform” rating on shares of DENTSPLY SIRONA in a report on Tuesday, November 1st. Robert W. Baird cut their price target on DENTSPLY SIRONA to $32.00 in a report on Thursday, November 17th. Finally, Piper Sandler lowered their price objective on DENTSPLY SIRONA from $38.00 to $29.00 in a research report on Monday, November 14th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $40.70.

DENTSPLY SIRONA Trading Down 0.8 %

XRAY opened at $30.37 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.04 and a current ratio of 1.50. The business has a 50 day moving average of $29.79 and a 200-day moving average of $33.95. DENTSPLY SIRONA has a 52 week low of $26.48 and a 52 week high of $58.70.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last released its earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 EPS for the quarter, missing analysts’ consensus estimates of $0.59 by ($0.18). The firm had revenue of $947.00 million during the quarter, compared to analysts’ expectations of $1.01 billion. DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. The company’s revenue for the quarter was down 8.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.68 EPS.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Parkside Financial Bank & Trust grew its stake in shares of DENTSPLY SIRONA by 163.7% during the first quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after buying an additional 568 shares during the last quarter. Wipfli Financial Advisors LLC bought a new position in DENTSPLY SIRONA in the third quarter worth approximately $27,000. Riverview Trust Co grew its stake in DENTSPLY SIRONA by 185.6% in the third quarter. Riverview Trust Co now owns 991 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 644 shares in the last quarter. SRS Capital Advisors Inc. bought a new position in DENTSPLY SIRONA in the third quarter worth approximately $28,000. Finally, Van ECK Associates Corp bought a new position in DENTSPLY SIRONA in the second quarter worth approximately $41,000. Institutional investors own 96.00% of the company’s stock.

DENTSPLY SIRONA Company Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Further Reading

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.